Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/10/19 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 04/08/19 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/01/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
159 |
| 04/01/19 | 8-K | Current report filing |
|
11 | |
| 02/25/19 | 8-K | Current report filing |
|
6 | |
| 01/08/19 | 8-K | Current report filing |
|
8 | |
| 01/08/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/04/19 | 8-K | Current report filing |
|
4 | |
| 12/31/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/20/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
